Literature DB >> 21129474

Prospective randomized controlled study of a Chinese herbal medicine compound Tangzu Yuyang Ointment for chronic diabetic foot ulcers: a preliminary report.

Shufa Li1, Jianyong Zhao, Jianping Liu, Fei Xiang, Debin Lu, Baoying Liu, Jing Xu, Huimin Zhang, Qian Zhang, Xianwen Li, Richeng Yu, Mingjun Chen, Xia Wang, Ye Wang, Bing Chen.   

Abstract

AIM OF THE STUDY: The purpose of this study was to evaluate the efficacy and safety of a topical Chinese herbal medicine (CHM) compound Tangzu Yuyang Ointment (TYO) for treatment of chronic diabetic foot ulcers.
MATERIALS AND METHODS: This multi-center, prospective, randomized, controlled and add-on clinical trial was conducted at seven centers in the China mainland. Fifty-seven patients with chronic diabetic foot ulcers of Wagner's ulcer grade 1-3 were enrolled in this study. Patients who were randomly assigned to the control group (n=28) received standard wound therapy (SWT), whereas those randomized to the treatment group (n=28) received SWT plus topical TYO. Only 48 patients who finished 24 weeks of observations were entered for data analysis.
RESULTS: The TYO and SWT groups were comparable for baseline characteristics. Ulcer improvement was 79.2% in the TYO group and 41.7% in the SWT group (P=0.017) at 12 weeks, and 91.7% vs. 62.5% (P=0.036) at 24 weeks. The number of ulcers that were completely healed at 4, 12 and 24 weeks was similar in both groups, as were the numbers of adverse events. Healing time was 96±56 days (n=19) in the TYO group and 75±53 days (n=14) in the SWT group (P=0.271).
CONCLUSION: TYO plus SWT is more effective than SWT in the management of chronic diabetic foot ulcers and has few side-effects. Crown Copyright Â
© 2010. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21129474     DOI: 10.1016/j.jep.2010.10.040

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  Evaluation of antibacterial activity, phytochemical constituents, and cytotoxicity effects of Thai household ancient remedies.

Authors:  Sasitorn Chusri; Naruephan Sinvaraphan; Ploypailin Chaipak; Atita Luxsananuwong; Supayang Piyawan Voravuthikunchai
Journal:  J Altern Complement Med       Date:  2014-12       Impact factor: 2.579

2.  Qualitative content analysis of complementary topical therapies used to manage diabetic foot in Jordan.

Authors:  Ma'en Zaid Abu-Qamar; Anne Wilson
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-04-02

3.  The effect of topical olive oil on the healing of foot ulcer in patients with type 2 diabetes: a double-blind randomized clinical trial study in Iran.

Authors:  Morteza Nasiri; Sadigheh Fayazi; Simin Jahani; Leila Yazdanpanah; Mohammad Hossein Haghighizadeh
Journal:  J Diabetes Metab Disord       Date:  2015-04-29

4.  EVALUATION OF EFFECTIVENESS IN A NOVEL WOUND HEALING OINTMENT-CROCODILE OIL BURN OINTMENT.

Authors:  Hua-Liang Li; Yi-Tao Deng; Zi-Ran Zhang; Qi-Rui Fu; Ya-Hui Zheng; Xing-Mei Cao; Jing Nie; Li-Wen Fu; Li-Ping Chen; You-Xiong Xiong; Dong-Yan Shen; Qing-Xi Chen
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-11-23

5.  Astragalus mongholicus Bunge and Panax notoginseng (Burkill) F.H. Chen Formula for Renal Injury in Diabetic Nephropathy-In Vivo and In Vitro Evidence for Autophagy Regulation.

Authors:  Dan Wen; Rui-Zhi Tan; Chang-Ying Zhao; Jian-Chun Li; Xia Zhong; Hui Diao; Xiao Lin; Dayue Darrel Duan; Jun-Ming Fan; Xi-Sheng Xie; Li Wang
Journal:  Front Pharmacol       Date:  2020-06-12       Impact factor: 5.810

Review 6.  Publicly Reported Wound Healing Rates: The Fantasy and the Reality.

Authors:  Caroline E Fife; Kristen A Eckert; Marissa J Carter
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-03-01       Impact factor: 4.730

7.  Network Pharmacology-Based Systematic Analysis of Molecular Mechanisms of Dingji Fumai Decoction for Ventricular Arrhythmia.

Authors:  Yi Liang; Bo Liang; Xin-Rui Wu; Wen Chen; Li-Zhi Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-08       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.